IDYA vs. IR

Last updated Aug 1, 2026

IDYA (IDEAYA Biosciences, Inc.) and IR (Ingersoll-Rand Plc) are both stocks. IDYA operates in Biotechnology (Healthcare), while IR operates in Specialty Industrial Machinery (Industrials). Over the past 5 years, IDYA returned 7.70%/yr vs 11.40%/yr for IR. Their 0.23 correlation means their historical movements had little consistent relationship.

Performance

IDYA vs. IR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IDYA achieves a 2.69% return, which is significantly lower than IR's 5.30% return.

IDYA

• 1D: -2.47%
• 1M: -5.71%
• 6M: 10.28%
• YTD: 2.69%
• 1Y: 46.27%
• 3Y*: 16.57%
• 5Y*: 7.70%
• 10Y*: —
• ALL TIME*: 13.82%

IR

• 1D: -1.11%
• 1M: 3.46%
• 6M: -3.10%
• YTD: 5.30%
• 1Y: 11.31%
• 3Y*: 8.20%
• 5Y*: 11.40%
• 10Y*: —
• ALL TIME*: 16.97%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
IDYA IDEAYA Biosciences, Inc.	$27.31M	$34.35M	$36.45M
IR Ingersoll-Rand Plc	$385.67M	$344.34M	$322.61M

IDYA vs. IR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
IDYA IDEAYA Biosciences, Inc.	2.69%	34.51%	-27.77%	95.82%	-23.14%	68.86%	86.67%	-46.43%
IR Ingersoll-Rand Plc	5.30%	-12.34%	17.06%	48.21%	-15.41%	35.85%	24.21%	8.31%

Correlation

The correlation between IDYA and IR is 0.18, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.18
Correlation (3Y) Balances recent behavior with more history.	0.29
Correlation (5Y) Shows whether the relationship held over a longer period.	0.28
Correlation (All Time) Calculated using the full available price history since May 23, 2019	0.23

The correlation between IDYA and IR shifts across timeframes, from 0.18 (1 year) to 0.29 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap IDYA : $3.38B IR : $32.63B
EPS IDYA : -$1.57 IR : $3.23
PS Ratio IDYA : 14.02 IR : 3.12
Total Revenue (TTM) IDYA : $225.27M IR : $7.94B
Gross Profit (TTM) IDYA : $215.25M IR : $3.01B
EBITDA (TTM) IDYA : -$157.90M IR : $1.83B

Return for Risk

IDYA vs. IR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

IDYA

IDYA Risk / Return Rank: 73
IDYA Sharpe Ratio Rank: 74
IDYA Sortino Ratio Rank: 72
IDYA Omega Ratio Rank: 70
IDYA Calmar Ratio Rank: 76
IDYA Martin Ratio Rank: 74

IR

IR Risk / Return Rank: 41
IR Sharpe Ratio Rank: 43
IR Sortino Ratio Rank: 38
IR Omega Ratio Rank: 38
IR Calmar Ratio Rank: 43
IR Martin Ratio Rank: 43

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

IDYA vs. IR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IDYA	IR	Difference
Sharpe ratio: Return per unit of total volatility	0.95	-0.04	+0.99
Sortino ratio: Return per unit of downside risk	1.57	0.19	+1.38
Omega ratio: Gain probability vs. loss probability	1.19	1.02	+0.17
Calmar ratio: Return relative to maximum drawdown	1.70	-0.05	+1.74
Martin ratio: Return relative to average drawdown	3.68	-0.10	+3.78

IDYA vs. IR - Sharpe Ratio Comparison

The current IDYA Sharpe Ratio is 0.95, which is higher than the IR Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of IDYA and IR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

IDYA vs. IR - Drawdown Comparison

The maximum IDYA drawdown since its inception was -78.36%, which is greater than IR's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for IDYA and IR.

Drawdown Indicators

	IDYA	IR	Difference
Max Drawdown Largest peak-to-trough decline	-78.36%	-50.27%	-28.09%
Max Drawdown (1Y) Largest decline over 1 year	-27.10%	-30.56%	+3.46%
Max Drawdown (3Y) Largest decline over 3 years	-69.23%	-36.62%	-32.61%
Max Drawdown (5Y) Largest decline over 5 years	-69.42%	-36.62%	-32.80%
Current Drawdown Current decline from peak	-24.68%	-20.74%	-3.94%
Average Drawdown Average peak-to-trough decline	-32.21%	-12.98%	-19.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.49%	13.84%	-1.35%

Volatility

IDYA vs. IR - Volatility Comparison

IDEAYA Biosciences, Inc. (IDYA) has a higher volatility of 13.09% compared to Ingersoll-Rand Plc (IR) at 10.46%. This indicates that IDYA's price experiences larger fluctuations and is considered to be riskier than IR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IDYA	IR	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.09%	10.46%	+2.63%
Volatility (6M) Calculated over the trailing 6-month period	35.77%	25.99%	+9.78%
Volatility (1Y) Calculated over the trailing 1-year period	48.73%	34.83%	+13.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	58.55%	30.29%	+28.26%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.95%	34.37%	+39.58%

Dividends

IDYA vs. IR - Dividend Comparison

IDYA has not paid dividends to shareholders, while IR's dividend yield for the trailing twelve months is around 0.10%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
IDYA IDEAYA Biosciences, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IR Ingersoll-Rand Plc	0.10%	0.10%	0.09%	0.10%	0.15%	0.03%	0.00%	5.78%

Financials

Frequently Asked Questions

Can I hold both IDYA and IR in my portfolio?

IDYA and IR have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IDYA or IR?

IDYA has higher volatility (13.09%) compared to IR (10.46%). In terms of maximum drawdown, IDYA dropped -78.36% vs IR's -50.27%.

Which has better risk-adjusted returns?

IDYA currently has the higher Sharpe Ratio (0.95 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.